Trial Profile

Study B2C111045, A Dose-Finding Study of GW642444 Versus Placebo in Patients With COPD.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 20 Dec 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vilanterol (Primary)
Indications Chronic obstructive pulmonary disease
Focus Adverse reactions; Pharmacogenomic; Therapeutic Use

Most Recent Events

12 Jan 2012 Results published in Chest.
22 Sep 2010 Safety results were presented at the 20th Annual Congress of the European Respiratory Society.
22 Sep 2010 Results presented at the European Respiratory Society congress, according to a GSK media release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com